Takeda Ventures into the Realm of Big Pharma with US$62 B Shire Buyout
By Heather Cartwright & Natasha Piper
Pharma Deals Review: Vol 2018 Issue 5 (Table of Contents)
Published: 22 May-2018
DOI: 10.3833/pdr.v2018.i5.2325 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Takeda Pharmaceutical has finally secured the backing of Shire’s Board of Directors for a £46 B (US$62...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018